Prevalence of symptoms in 1512 COVID-19 patients: have dizziness and vertigo been underestimated thus far?

Author:

Aldè MirkoORCID,Barozzi StefaniaORCID,Di Berardino FedericaORCID,Zuccotti GianvincenzoORCID,Consonni DarioORCID,Ambrosetti UmbertoORCID,Socci Marina,Bertoli SimonaORCID,Battezzati AlbertoORCID,Foppiani AndreaORCID,Zanetti DiegoORCID,Pignataro LorenzoORCID,Cantarella GiovannaORCID

Abstract

AbstractThe relationship between SARS-CoV-2 infection and dizziness is still unclear. The aim of this study is to assess the prevalence and characteristics of dizziness and vertigo among patients with mild-to-moderate COVID-19. Patients discharged from the emergency rooms with a confirmed SARS-CoV-2 diagnosis were assisted by daily telephone calls until nasopharyngeal swab negativization, and specific symptoms concerning balance disorders were investigated through targeted questions posed by experienced physicians. The study included 1512 subjects (765 females, 747 males), with a median age of 51 ± 18.4 years. New-onset dizziness was reported by 251 (16.6%) patients, among whom 110 (43.8%) complained of lightheadedness, 70 (27.9%) of disequilibrium, 41 (16.3%) of presyncope, and 30 (12%) of vertigo. This study analyzed in detail the prevalence and pathophysiological mechanisms of the different types of balance disorders in a large sample, and the results suggest that dizziness should be included among the main symptoms of COVID-19 because one-sixth of patients reported this symptom, with females being significantly more affected than males (20.3 vs 12.9%, P < 0.001). Most cases of dizziness were attributable to lightheadedness, which was probably exacerbated by psychophysical stress following acute infection and mandatory quarantine. Vertigo should not be underestimated because it might underlie serious vestibular disorders, and disequilibrium in elderly individuals should be monitored due to the possible risk of falls.

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Reference48 articles.

1. European Centre for Disease Prevention and Control (2021) COVID-19 situation update worldwide, as of week 48, updated 9 November 2021. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases. Accessed 15 Nov 2021

2. Krishnan A, Hamilton JP, Alqahtani SA, Woreta TA (2021) A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations. Intern Emerg Med 16(4):815–830. https://doi.org/10.1007/s11739-020-02616-5

3. Lechien JR, Chiesa-Estomba CM, Place S et al (2020) Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med 288(3):335–344. https://doi.org/10.1111/joim.13089

4. World Health Organization (2021) Coronavirus. https://www.who.int/health-topics/coronavirus#tab=tab_3. Accessed 15 Nov 2021

5. Centers for Disease Control and Prevention (2021) Symptoms of COVID-19. Updated Feb. 22, 2021. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Accessed 15 Nov 2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3